Peter D. Kies
2023
In 2023, Peter D. Kies earned a total compensation of $1.2M as Chief Financial Officer at Inovio Pharmaceuticals, a 28% decrease compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $172,314 |
---|---|
Option Awards | $218,593 |
Salary | $622,881 |
Stock Awards | $132,252 |
Other | $15,000 |
Total | $1,161,040 |
Kies received $622.9K in salary, accounting for 54% of the total pay in 2023.
Kies also received $172.3K in non-equity incentive plan, $218.6K in option awards, $132.3K in stock awards and $15K in other compensation.
Rankings
In 2023, Peter D. Kies' compensation ranked 1,018th out of 2,785 executives tracked by ExecPay. In other words, Kies earned more than 63.4% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 1,018 | 63rd |
Manufacturing | 610 | 60th |
Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 71 | 69th |
Surgical, Medical, And Dental Instruments And Supplies | 44 | 73rd |
Surgical and Medical Instruments and Apparatus | 39 | 69th |
Kies' colleagues
We found two more compensation records of executives who worked with Peter D. Kies at Inovio Pharmaceuticals in 2023.
News
Inovio Pharmaceuticals CEO Jacqueline Shea's 2023 pay falls 31% to $2.4M
April 11, 2024
Inovio Pharmaceuticals CEO J Kim's 2022 pay jumps 68% to $10M
March 28, 2023
Inovio Pharmaceuticals CEO J Kim's 2021 pay jumps 32% to $6.2M
March 25, 2022
Inovio Pharmaceuticals CEO J Kim's 2020 pay jumps 82% to $4.7M
March 25, 2021
Inovio Pharmaceuticals CEO J Kim's 2018 pay falls 30% to $3.1M
March 25, 2019